20 PF-08634404 (SSGJ-707), a Tetravalent PD-1/VEGF Bispecific Antibody for the Treatment of Renal Cell Carcinoma (NCT07227415)

Toni Choueiri, Sumanta Pal, Thomas Powles, Meghan Zuck, Catalina Sakai, Eliana Moskovitz, Laila Shehata, Markus Carlson, Florian Heinkel, Sherif Abdelhamed, Michelle Ulrich, Matthew Rathgeber, Gregory Szeto, Brian O’Connor, Joseph Dekker, Ryan Heiser, Brian Rini · 2026

Read 20 PF-08634404 (SSGJ-707), a Tetravalent PD-1/VEGF Bispecific Antibody for the Treatment of Renal Cell Carcinoma (NCT07227415) by Toni Choueiri, Sumanta Pal, Thomas Powles, Meghan Zuck, Catalina Sakai, Eliana Moskovitz, Laila Shehata, Markus Carlson, Florian Heinkel, Sherif Abdelhamed, Michelle Ulrich, Matthew Rathgeber, Gregory Szeto, Brian O’Connor, Joseph Dekker, Ryan Heiser, Brian Rini (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13535419.txt.

Description

Toni Choueiri and co-authors describe a new drug for kidney cancer in a 2026 conference report. The drug, PF-08634404, is a lab-made protein that blocks two targets at once: PD-1, a brake on immune cells, and VEGF, a signal that helps tumors grow new blood vessels. Its four-armed shape helps the two ends work together.

Kidney tumors often use both paths, so blocking both with one drug may work better than giving two drugs apart. The report sets out how the drug binds each target and why that joint action could raise its effect on the tumor. It frames the case for testing the drug in people with this cancer.

Catalog record

CREATORToni Choueiri, Sumanta Pal, Thomas Powles, Meghan Zuck, Catalina Sakai, Eliana Moskovitz, Laila Shehata, Markus Carlson, Florian Heinkel, Sherif Abdelhamed, Michelle Ulrich, Matthew Rathgeber, Gregory Szeto, Brian O’Connor, Joseph Dekker, Ryan Heiser, Brian Rini
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE4 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13535419

Browse the full library · About the Tower of Babel